Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Sepsis Market?
There has been substantial growth in the sepsis market size in the past few years. It is projected to expand from $0.93 billion in 2024 to $1.02 billion in 2025, registering a compound annual growth rate (CAGR) of 9.3%. The robust growth observed in the historical phase is a result of increased incidences of sepsis amongst older populations, a surge in cases of chronic diseases, raised consciousness regarding sepsis amongst medical service providers, rising healthcare spending, and the application of government strategies for early diagnosis and treatment.
What Growth Rate Is Forecasted for the Sepsis Market by 2029?
It is projected that the sepsis market will witness substantial expansion in the upcoming years, reaching $1.44 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.0%. Factors motivating this predicted boost during the forecast period include the surging use of artificial intelligence in critical care sectors, increasing instances of multi-drug-resistant infections, rising awareness about sepsis through campaigns, improvement in healthcare facilities in developing economies, and augmented investments poured into biotechnology and pharmaceutical research. Key trends for the forecast duration encompass the development of swift point-of-care diagnostics, the uptake of predictive analytics powered by AI, personalized antibiotic stewardship initiatives, progress in blood culture methods, discovery of innovative biomarkers, and the evolution of new therapies focusing on immune modulation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp
Which Key Companies Are Shaping the Future of the Sepsis Market?
Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
Which Factors Are Driving Demand in the Sepsis Industry?
The expected escalation in the sepsis market is attributed to the rising prevalence of infectious diseases. Such diseases, triggered by the invasion of bacteria, viruses, fungi, or parasites, incorporate common illnesses like tuberculosis, flu, ringworm, and malaria. These can get transmitted through direct contact, through infected mediums, or via insect carriers. Factors such as growth, globalization, change in environment, drug-resistant pathogens, and loopholes in healthcare systems contribute to the spread of these diseases. Sepsis emerges as a critical complication from infectious diseases, resulting from the body’s extreme reaction resulting in inflammation and potentially, organ failure. For instance, as per the November 2024 reports by the Centers for Disease Control and Prevention, a US public health government agency, the United States witnessed a substantial 15.6% rise in tuberculosis (TB) cases from 8,332 in 2022 to 9,633 in 2023. This continuous surge in infectious diseases, thus, infers a consistent growth in the sepsis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21286&type=smp
How Is the Sepsis Market Segmented by Several Divisions?
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
What are the Emerging Market Trends Driving the Growth of the Sepsis Industry?
Leading firms in the sepsis market are concentrating on developing state-of-the-art platforms, such as those powered by artificial intelligence (AI), to facilitate early detection, enhance the accuracy of treatment, and forecast patient outcomes, all in an effort to lessen death rates and improve healthcare efficiency in managing sepsis. For example, in June 2024, Predicate Healthcare Performance Group (HPG), an American healthcare company, introduced its AI-driven software platform, OpenDX. This revolutionary platform merges AI-based diagnostics with wearable biosensors, allowing healthcare professionals to identify early indications of sepsis. This assists in diagnosing sepsis and might potentially be applied to other health issues, underscoring the importance of technology in diagnostics. Predicate’s chest sensor enables healthcare practitioners to identify early signs of sepsis, a difficult and frequently overlooked diagnosis.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
Which Regions Are Driving Growth in the Sepsis Market?
North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21286
This Report Delivers Insight On:
1. How big is the sepsis market, and how is it changing globally?
2. Who are the major companies in the sepsis market, and how are they performing?
3. What are the key opportunities and risks in the sepsis market right now?
4. Which products or customer segments are growing the most in the sepsis market?
5. What factors are helping or slowing down the growth of the sepsis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model